MNPR
Monopar Therapeutics Inc
NASDAQ: MNPR · HEALTHCARE · BIOTECHNOLOGY
$52.15
+4.05% today
Updated 2026-04-30
Market cap
$361.51M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.85
Dividend yield
—
52W range
$28 – $105
Volume
0.2M
Monopar Therapeutics Inc (MNPR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-14.20%
ROA
-10.40%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-687000.00 | — | — | — |
| 2016 | $0.00 | $-1.19M | — | — | — |
| 2017 | $0.00 | $-16.55M | — | — | — |
| 2018 | $0.00 | $-3.23M | — | — | — |
| 2019 | $0.00 | $-4.13M | — | — | — |
| 2020 | $122400.00 | $-6.30M | 100.00% | -5,317.71% | -5,150.79% |
| 2021 | $0.00 | $-9.08M | — | — | — |
| 2022 | $0.00 | $-10.49M | — | — | — |
| 2023 | $0.00 | $-8.40M | — | — | — |
| 2024 | $0.00 | $-15.59M | — | — | — |
| 2025 | $0.00 | $-13.72M | — | — | — |